急性痛风的自发解决:机制和治疗目标
Meiling Shi1,2,3,4, Jiao Luo2,3,4, Liting Ding2,3,4
1Medical College of Nanchang University, Nanchang, China.
RMD open
|September 21, 2023
概括
痛风发作通常会自行消失,但这种自发缓解的确切原因尚未完全理解. 对这些机制的进一步研究对于开发新的痛风治疗方法至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 结晶诱导的关节病症 结晶诱导的关节病
背景情况:
- 痛风是一种常见的炎症性关节炎,与单酸盐晶体沉积和高尿血症有关.
- 痛风患病率的增加需要更好的慢性和耐火病例管理策略.
- 急性痛风发作通常在7-10天内自行解决,但潜在的机制仍然不清楚.
研究的目的:
- 阐明急性痛风发作自发缓解背后的机制.
- 审查各种因素的作用,有助于痛风自我解决.
- 为开发针对性治疗治疗痛风管理提供见解.
主要方法:
- 文献综述和综合关于痛风病原和自发缓解的现有研究.
- 对调查急性痛风发作解决阶段的研究进行分析.
- 检查参与结晶清除和减少炎症的免疫和生化途径.
主要成果:
- 自发缓解涉及炎症解决途径的复杂相互作用.
- 诸如补体系统调制和细胞活动等因素都与此有关.
- 了解这些机制是确定治疗点的关键.
结论:
- 痛风爆发的自发解决是一个复杂的生物过程.
- 进一步阐明这些机制对于推进痛风治疗至关重要.
- 根据这些发现,有针对性的疗法可以改善慢性痛风患者的治疗结果.
相关概念视频
Inflammatory Response
2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
Acute Pancreatitis II: Clinical Manifestations and Management
142
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
142
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
GPCR Desensitization
6.1K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
Inflammatory Bowel Disease IV: Pharmacological Management
145
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
145


